Compatible Solutes Inhibit Ceramide Release to Prevent Skin Aging

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Exposure to UV light leads to the release of ceramides in human skin cells, triggering a metabolic cascade that results in premature skin aging and wrinkling, as it increases the synthesis of pro-inflammatory proteins and reactive oxygen species, damaging skin cells and collagen fibers.

Innovation Solution

The use of compatible solutes, such as trehalose, glycerol, and ectoin derivatives, which inhibit the release of ceramides from membrane-bound sphingomyelin induced by UV light and free radicals, thereby preventing the expression of matrix metalloproteinases and pro-inflammatory proteins, and protecting collagen fibers and skin cells from damage.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If UV light exposure occurs, then skin cells are activated and metabolic processes occur, but ceramides are released triggering harmful metabolic cascades leading to skin aging and damage

Engineering Contradiction:
Improveskin cell functionVSAvoidceramide release and metabolic cascade damage
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The patent applies preliminary anti-action by using compatible solutes to prevent ceramide release before the harmful metabolic cascade can occur. The compatible solutes are applied to the skin in advance of UV exposure or immediately thereafter to block the release of ceramides from the cell membrane, thereby preventing the activation of transcription factor AP-2 and subsequent expression of pro-inflammatory genes and matrix metalloproteinases that would otherwise lead to collagen degradation and skin aging.

Inventive Principle:
Principle #9Preliminary anti-action

Solution Approach 2:

The patent uses compatible solutes as intermediary substances that mediate between UV light exposure and the cell membrane. These solutes (such as trehalose, glycerol, and ectoin derivatives) accumulate in the cytoplasm and act as protective intermediaries that stabilize the cell membrane structure, preventing UV-induced ceramide release without interfering with normal cellular metabolism or function.

Inventive Principle:
Principle #24Intermediary (Mediator)

2Productivity

If ceramides are released from membrane-bound sphingomyelin, then transcription factor AP-2 is activated and pro-inflammatory proteins are synthesized, but skin cells and collagen fibers are damaged

Engineering Contradiction:
Improvemetabolic activityVSAvoidpro-inflammatory proteins and reactive oxygen species
Core Design Contradiction:
ProductivityVSObject-generated harmful factors

Solution Approach 1:

The patent applies preliminary action by having compatible solutes accumulate in the cytoplasm before UV stress occurs, preparing the cell for potential damage. These solutes are taken up by the cells through transport mechanisms or biosynthesis in advance, creating a protective reservoir that can immediately counteract ceramide release when UV exposure occurs, thereby preventing the harmful metabolic cascade before it fully develops.

Inventive Principle:
Principle #10Preliminary action

3Quantity of substance

If matrix metalloproteinases are expressed, then collagen fibers are degraded, but skin structure and elasticity are compromised

Engineering Contradiction:
Improvecollagen fiber integrityVSAvoidskin structure and elasticity
Core Design Contradiction:
Quantity of substanceVSStrength

Solution Approach 1:

The patent converts the harmful effect of UV exposure into a beneficial outcome by using the same UV-stressed conditions to demonstrate the protective effect of compatible solutes. Under UV stress, cells that have accumulated compatible solutes actually benefit from the stress condition, as the solutes trigger protective mechanisms that enhance cell survival and collagen protection, effectively converting the harmful UV exposure into an opportunity to demonstrate and activate protective pathways.

Inventive Principle:
Principle #22Blessing in disguise (Convert harm into benefit)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

Inhibiting the release of ceramides with compatible solutes effectively prevents skin cell damage, reduces the degradation of collagen fibers, and protects the skin against premature aging and wrinkling by interrupting the UV-induced metabolic cascade at its early stages, offering protection against pro-inflammatory substances and reactive oxygen species.

Implementation Method 1

These osmotically active substances prevent liquid outflow into the medium (drying out) and owe their name to the fact that they do not impair cell metabolism, even in high cytoplasmic concentration

Methodology Applied
Scientific EffectOsmotic protection: Osmotic Pressure

Data Source

PatentUS7981899B2Use of compatible solutes for inhibiting the release of ceramides
Publication Date: 2011.07.19 SUSONITY COMMERCIAL GMBH
  • US7981899B2 patent drawing
  • US7981899B2 patent drawing
  • US7981899B2 patent drawing

AI summary

Disclosed are the use of compatible solutes for inhibiting the release of ceramides or for the prophylaxis and protection of human skin against premature skin aging and for the prophylaxis and protection of human skin against wrinkling.